Developmental Therapeutics Research Program
KL-50:A cell line selective DNA cross-linking agent for the treatment of drug-resistant glioblastoma
Developmental Therapeutics Research Program
KL-50:A cell line selective DNA cross-linking agent for the treatment of drug-resistant glioblastoma
Speaker
Contact
Hosts
Admission
Free
Tag
Lectures and Seminars
Food
Lunch: Lunch Provided